Compounds > coumarin
Page last updated: 2024-10-17

coumarin and Triple Negative Breast Neoplasms

coumarin has been researched along with Triple Negative Breast Neoplasms in 1 studies

2H-chromen-2-one: coumarin derivative

Triple Negative Breast Neoplasms: Breast neoplasms that do not express ESTROGEN RECEPTORS; PROGESTERONE RECEPTORS; and do not overexpress the NEU RECEPTOR/HER-2 PROTO-ONCOGENE PROTEIN.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Mbaba, M1
Dingle, LMK1
Zulu, AI1
Laming, D1
Swart, T1
de la Mare, JA1
Hoppe, HC1
Edkins, AL1
Khanye, SD1

Other Studies

1 other study available for coumarin and Triple Negative Breast Neoplasms

ArticleYear
Coumarin-Annulated Ferrocenyl 1,3-Oxazine Derivatives Possessing In Vitro Antimalarial and Antitrypanosomal Potency.
    Molecules (Basel, Switzerland), 2021, Mar-02, Volume: 26, Issue:5

    Topics: Antimalarials; Antiprotozoal Agents; Cell Proliferation; Cell Survival; Coumarins; Female; Ferrous C

2021